The new Covid-preventing pill “could prevent lockdowns”.
Pfizer has quickly become a household name in the last six months, after the US pharmaceutical company developed the world’s first vaccine officially rolled out to prevent Covid-19. The UK’s first Pfizer/BioNTech dose was given on December 8, 2020, and has continued to be dished out in the nations vaccination efforts. Since this date, nearly 35 million people in Britain have received a jab, be it from Pfizer, or the AstraZeneca and Moderna varieties. [Featured Image: nokwalai, Shutterstock].
Now, it is looking like Pfizer could deliver another component for the world’s battle against Coronavirus, in the form of a “Covid-preventing pill”. Human trials are being performed in both the US and Europe, and there is hope that the pill could be widely available by the end of this year.
This would mark the first drug of its kind, and would work alongside vaccines to boost the hope of avoiding lockdowns for good.
Named PF-07321332, it is hoped that the drug would halt serious illness from Covid-19, and would be a necessary addition to tackle the issue of new, vaccine-resistant strains of the virus. As reported in The Daily Telegraph, the pill is in the trial-phase in two anonymous Pfizer buildings in the US and Belgium. This first trial phase is expected to conclude next month, which will be followed by a larger trial if it is successful in fighting Covid-19.